Retrospective Evaluation Of Sars-Cov-2 In A Riverine Community Of Niger Delta, Nigeria Using Real-Time Polymerase Chain Reaction
Main Article Content
Abstract
Introduction: Global health systems are battling with the changing COVID 19 prevalence globally due to a diversity of factors. This study was carried out in a riverine community in the Niger Delta to determine the Prevalence of SARS nCov 2.
Materials and Methods: The samples were collected aseptically from the suspected patients into a virus transport medium and sent to the molecular laboratory in the cold chain for processing. After inactivation and RNA extraction procedures, all RNA extracts in the Eppendorf tube stored at -20oC were used as a template for PCR amplification with the Life-River Master-Mix procedure according to the manufacturer's instructions.
Results: This study involved 899 subjects, both male (508) and female (391), in the ratio of 1.3:1. Age group prevalence of males in this study revealed age group 31-40 years (3.23%) as the highest while male prevalence was 11.7% (105/899) and female was Prevalence 8.5% (76/899).
Conclusion: This study showed a moderate infection rate of COVID 19 among the population of people living in Yenagoa and calls for utmost preventive action to be strictly adhered to by the populace.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Ejela T. Probable factors contributing to the fast spread of the novel coronavirus (COVID-19) in Ethiopia. J Infect Dis Epidemiol. 2020; 6:169. doi: 10.23937/2474-3658/1510169.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu, Z, Zhong W, Xiao G. Cell Research. 2020; 53(3): 436–443.
Medscape. Coronavirus Disease 2019 (COVID-19) triage precautions. 2022. Available from: https://emedicine.medscape.com/article/2500120-overview
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu J, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. DOI: 10.1016/S0140-6736(20)30183-5.
Cascella M, Rajnik M, Aleem A, et al. Features, Evaluation, and Treatment of Coronavirus (COVID19) [Updated 2023 Aug 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen.j, Luo Y, Guo, H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273.
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020; 8:152. https://doi.org/10.3389/fpubh.2020.00152 8. Dong Y, Mo XI, Hu Y, Qi X, Jiang F, Jiang Z et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;145(6):e20200702.
Viner RM, Russell SJ, Croker H, Packer J, Ward J, Stansfield C, Mytton O, Bonell C, Booy R. ‘School closure and management practices during coronavirus outbreaks including COVID-19: A rapid systematic review’. The Lancet Child & Adolescent Health. 2020;4(5):397-404.
World Health Organization (WHO). Coronavirus disease (COVID-19) pandemic. 2020. Available from: https://www.who.int/emergencies/diseases/novelcoronavirus-2019
Centers for Disease Control and Prevention (CDC). COVID-19 and older adults. 2020; Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/needextra-precautions/older-adults.html
Alpdagtas S, Elif I, Ebru U, Mustafa S, Cem BU, Gunduz O. Evaluation of current diagnostic methods for COVID-19. APL Bioeng. 2020; 1:4(4)
Egbi OE, Duru C, Kasia B. Knowledge, attitude and practice towards COVID-19 among workers of a tertiary hospital in Bayelsa State, Nigeria. Pan African Medical Journal.2020; 37(1): 24. 10.11604/pamj.supp.2020.37.24.26259
Chowdhury SD, Oommen AN. Epidemiology of COVID-19. Journal of Digestive Endoscopy. 2020; 11(1): 3–7. doi: 10.1055/s-0040-1712187 PMCID: PMC7364648.
Salako AO, Amoo OS, Odubela OO, Osuolale KA, James AB, Oladele DA. Prevalence and clinical characteristics of coronavirus disease 2019 seen at a testing centre in Lagos, Nigeria. West Afr J Med. 2021;38(1):54-8.
Barrett ES, Horton DB, Roy J, Xia W, Greenberg P, Andrews T, Gennaro ML, Parmar V, Russell WD, Reilly N, Uprety P, Gantner JJ, Stockman L, Trooskin SZ, Blaser MJ, Carson JL, Panettieri RA Jr. Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospital Workers: Results From a Screening Study in New Jersey, United States in Spring 2020. InOpen forum infectious diseases 2020;7(12), p. ofaa534). US: Oxford University Press
Buonafine CP, Piatto BNM, Leal FB, de Matos SF, de Morais CO, Guerra GG, et al. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil. BMC Infect Dis. 2020;20:1-8.
Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626-38. https://doi.org/10.1038/nri.2016.90.